GLP1R and hydrops fetalis: Although GLP-1 receptor agonists expected the cardioprotective effects due to the abundant expression of GLP-1 receptor in human myocardium, clinical trials revealed no improvements in HF hospitalization [6], whereas improvements in cardiac contraction [28] and a significant reduction in cardiovascular death were seen [29].